Cargando…

Human CD141(+) Dendritic Cell and CD1c(+) Dendritic Cell Undergo Concordant Early Genetic Programming after Activation in Humanized Mice In Vivo

Human immune cell subsets develop in immunodeficient mice following reconstitution with human CD34(+) hematopoietic stem cells. These “humanized” mice are useful models to study human immunology and human-tropic infections, autoimmunity, and cancer. However, some human immune cell subsets are unable...

Descripción completa

Detalles Bibliográficos
Autores principales: Minoda, Yoshihito, Virshup, Isaac, Leal Rojas, Ingrid, Haigh, Oscar, Wong, Yide, Miles, John J., Wells, Christine A., Radford, Kristen J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5670352/
https://www.ncbi.nlm.nih.gov/pubmed/29163495
http://dx.doi.org/10.3389/fimmu.2017.01419
Descripción
Sumario:Human immune cell subsets develop in immunodeficient mice following reconstitution with human CD34(+) hematopoietic stem cells. These “humanized” mice are useful models to study human immunology and human-tropic infections, autoimmunity, and cancer. However, some human immune cell subsets are unable to fully develop or acquire full functional capacity due to a lack of cross-reactivity of many growth factors and cytokines between species. Conventional dendritic cells (cDCs) in mice are categorized into cDC1, which mediate T helper (Th)1 and CD8(+) T cell responses, and cDC2, which mediate Th2 and Th17 responses. The likely human equivalents are CD141(+) DC and CD1c(+) DC subsets for mouse cDC1 and cDC2, respectively, but the extent of any interspecies differences is poorly characterized. Here, we exploit the fact that human CD141(+) DC and CD1c(+) DC develop in humanized mice, to further explore their equivalency in vivo. Global transcriptome analysis of CD141(+) DC and CD1c(+) DC isolated from humanized mice demonstrated that they closely resemble those in human blood. Activation of DC subsets in vivo, with the TLR3 ligand poly I:C, and the TLR7/8 ligand R848 revealed that a core panel of genes consistent with DC maturation status were upregulated by both subsets. R848 specifically upregulated genes associated with Th17 responses by CD1c(+) DC, while poly I:C upregulated IFN-λ genes specifically by CD141(+) DC. MYCL expression, known to be essential for CD8(+) T cell priming by mouse DC, was specifically induced in CD141(+) DC after activation. Concomitantly, CD141(+) DC were superior to CD1c(+) DC in their ability to prime naïve antigen-specific CD8(+) T cells. Thus, CD141(+) DC and CD1c(+) DC share a similar activation profiles in vivo but also have induce unique signatures that support specialized roles in CD8(+) T cell priming and Th17 responses, respectively. In combination, these data demonstrate that humanized mice provide an attractive and tractable model to study human DC in vitro and in vivo.